Cargando…
A study on changes of coagulation inhibitors and fibrinolysis inhibitors in patients with liver cirrhosis and hepatoma.
The authors conducted an investigation focusing mainly on the activities of the inhibitory factors of the coagulation and fibrinolysis processes in 35 normal adults and 72 liver cirrhosis and/or hepatoma patients. The activities of antithrombin III, protein C, and alpha 2-plasmin inhibitor were redu...
Autores principales: | Park, C. J., Cho, H. I., Kim, S. I. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Korean Academy of Medical Sciences
1991
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3049674/ https://www.ncbi.nlm.nih.gov/pubmed/1653574 |
Ejemplares similares
-
Intraperitoneal Activation of Coagulation and Fibrinolysis in Patients with Cirrhosis and Ascites
por: Thaler, Johannes, et al.
Publicado: (2021) -
Mortality of hepatoma and cirrhosis of liver in Taiwan.
por: Lin, T. M., et al.
Publicado: (1986) -
Standardization of Coagulation and Fibrinolysis Methods
por: Jespersen, Jörgen
Publicado: (2000) -
Thrombin-activatable fibrinolysis inhibitor and organ dysfunction in disseminated intravascular coagulation associated with sepsis
por: Hayakawa, M, et al.
Publicado: (2011) -
Coagulation and fibrinolysis after head injury
por: Homma, M, et al.
Publicado: (1998)